Stephen M Bowen

Title: The Innovative Contributions of Stephen M. Bowen

Introduction

Stephen M. Bowen is a notable inventor based in Cincinnati, OH. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds aimed at preventing tissue damage caused by free radicals. His work has implications for various disease states, showcasing the importance of innovation in medical science.

Latest Patents

Stephen M. Bowen holds a patent for "Cyclic nitrones." This invention is directed towards novel cyclic nitrones and their application in preventing oxidation tissue damage by free radicals. The patent also covers their use in treating diseases where radicals can damage or destroy tissues through oxidation, along with pharmaceutical compositions that incorporate these cyclic nitrones.

Career Highlights

Stephen has worked at Hoechst Marion Roussel, a company known for its commitment to pharmaceutical advancements. His role there has allowed him to focus on innovative solutions that address critical health issues. His patent reflects his dedication to improving patient outcomes through scientific research and development.

Collaborations

Stephen has collaborated with notable colleagues, including Craig E. Thomas and Thomas L. Fevig. These partnerships have likely contributed to the success of his projects and the advancement of their shared goals in the pharmaceutical industry.

Conclusion

Stephen M. Bowen's work exemplifies the impact of innovation in healthcare. His patent on cyclic nitrones represents a significant step forward in the fight against tissue damage caused by free radicals. Through his career and collaborations, he continues to contribute to the advancement of medical science.